Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Huntington Agent SKY-0515 Shows Favorable Trends Across cUHDRS Subcomponents in 12-Month Findings
2
FDA Accepts Sarepta's sNDAs for Casimersen and Golodirsen for Duchenne Muscular Dystrophy
3
FDA Advisory Committee Schedules Meeting to Review Deramiocel's BLA in Duchenne Muscular Dystrophy
4
Clinical Opinion: EU Approval of Tolebrutinib Signals New Direction for Nonrelapsing Secondary Progressive MS
5